Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gliosarcoma × abexinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Oligodendroglioma 1 Lymphoma, Large B-Cell, Diffuse 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Carcinoma, Renal Cell 1 Astrocytoma 1

Interventions

Temozolomide 3 Specimen Handling 2 Radiotherapy 2 peposertib 1 pembrolizumab 1 gosha-jinki-gan 1 efineptakin alfa 1 cabozantinib 1 atezolizumab 1 abexinostat 1 Radiation 1 ONC206 1 Ipilimumab 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05698524 2025-05-20

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

University of Nebraska

Phase 1 Recruiting

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡